Gotham Asset Management LLC grew its position in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 25.2% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 27,942 shares of the biotechnology company's stock after acquiring an additional 5,620 shares during the quarter. Gotham Asset Management LLC's holdings in Axon Enterprise were worth $14,696,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also made changes to their positions in AXON. TCTC Holdings LLC boosted its stake in Axon Enterprise by 75.0% during the first quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company's stock worth $29,000 after buying an additional 24 shares during the last quarter. Fourth Dimension Wealth LLC purchased a new stake in Axon Enterprise in the fourth quarter valued at $30,000. Bartlett & CO. Wealth Management LLC raised its position in Axon Enterprise by 132.0% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company's stock valued at $31,000 after purchasing an additional 33 shares during the period. Banque Transatlantique SA purchased a new stake in Axon Enterprise in the first quarter valued at $31,000. Finally, Catalyst Capital Advisors LLC purchased a new stake in Axon Enterprise in the first quarter valued at $32,000. Hedge funds and other institutional investors own 79.08% of the company's stock.
Axon Enterprise Price Performance
Axon Enterprise stock traded up $0.55 during mid-day trading on Thursday, hitting $748.10. 299,583 shares of the company were exchanged, compared to its average volume of 686,577. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.95 and a quick ratio of 2.71. The business's 50 day simple moving average is $762.78 and its two-hundred day simple moving average is $682.93. The company has a market capitalization of $58.73 billion, a P/E ratio of 184.72, a PEG ratio of 26.87 and a beta of 1.40. Axon Enterprise, Inc has a 12-month low of $364.60 and a 12-month high of $885.91.
Axon Enterprise (NASDAQ:AXON - Get Free Report) last issued its earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, beating analysts' consensus estimates of $1.54 by $0.58. The firm had revenue of $668.54 million for the quarter, compared to analysts' expectations of $641.77 million. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The firm's revenue for the quarter was up 32.6% compared to the same quarter last year. During the same quarter last year, the firm earned $1.20 earnings per share. Axon Enterprise has set its FY 2025 guidance at EPS. Analysts forecast that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.
Analysts Set New Price Targets
A number of equities research analysts have commented on the company. UBS Group restated a "neutral" rating and issued a $840.00 target price (up previously from $820.00) on shares of Axon Enterprise in a research report on Tuesday, August 5th. Northland Securities set a $800.00 price objective on Axon Enterprise in a report on Tuesday, August 5th. The Goldman Sachs Group boosted their target price on Axon Enterprise from $730.00 to $830.00 and gave the stock a "buy" rating in a research note on Wednesday, May 14th. Needham & Company LLC set a $870.00 price objective on Axon Enterprise and gave the stock a "buy" rating in a research report on Tuesday, August 5th. Finally, Raymond James Financial reaffirmed an "outperform" rating and set a $855.00 price objective (up from $645.00) on shares of Axon Enterprise in a research report on Tuesday, August 5th. Thirteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, Axon Enterprise currently has an average rating of "Moderate Buy" and an average target price of $837.69.
Check Out Our Latest Stock Analysis on Axon Enterprise
Insider Activity at Axon Enterprise
In other Axon Enterprise news, Director Hadi Partovi acquired 1,358 shares of Axon Enterprise stock in a transaction dated Wednesday, August 13th. The stock was acquired at an average cost of $740.00 per share, for a total transaction of $1,004,920.00. Following the completion of the transaction, the director owned 237,938 shares in the company, valued at approximately $176,074,120. This represents a 0.57% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Jeffrey C. Kunins sold 7,891 shares of the stock in a transaction on Thursday, August 14th. The shares were sold at an average price of $750.10, for a total value of $5,919,039.10. Following the transaction, the insider directly owned 144,538 shares of the company's stock, valued at approximately $108,417,953.80. The trade was a 5.18% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 44,865 shares of company stock valued at $34,362,833. 4.40% of the stock is owned by insiders.
Axon Enterprise Company Profile
(
Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Read More

Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.